Wells Fargo’s Coya Therapeutics COYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.5K Hold
500
– – ﹤0.01% 6365
2026
Q2
$2.92K Hold
500
– – ﹤0.01% 6312
2026
Q1
$1.97K Buy
+500
New +$2.34K ﹤0.01% 6252
2024
Q2
– Sell
-100
Closed -$992 – 7002
2024
Q1
$992 Buy
100
+35
+54% +$274 ﹤0.01% 6153
2023
Q4
$482 Buy
65
+4
+7% +$22 ﹤0.01% 6393
2023
Q3
$234 Buy
61
+38
+165% +$151 ﹤0.01% 6547
2023
Q2
$94 Buy
23
+1
+5% +$5 ﹤0.01% 6881
2023
Q1
$87 Buy
+22
New +$96 ﹤0.01% 6964

Other funds holding COYA

Wells Fargo's COYA Position: Q3 2026 in Review

Wells Fargo held its Coya Therapeutics (COYA) position steady in Q3 2026 at 500 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6365.

Wells Fargo first reported a position in COYA in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.92K in Q2 2026. 52 funds tracked by Wall St. Rank hold COYA as of Q3 2026.

  • Wells Fargo held 500 shares of Coya Therapeutics worth $2.5K as of Q3 2026.
  • Wells Fargo left its Coya Therapeutics share count unchanged in Q3 2026.
  • Coya Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #6365 holding.
  • Wells Fargo first reported a position in Coya Therapeutics in Q1 2023 and has held it in 8 quarters since.
  • Wells Fargo's Coya Therapeutics position peaked at $2.92K in Q2 2026.
  • 52 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.